Marc Iskowitz

Most Recent Articles by Marc Iskowitz

Five things for pharma marketers to know: Friday, February 2

Five things for pharma marketers to know: Friday, February 2

By

AstraZeneca strikes deals with Alibaba, Tencent; NY AG sues opioid maker; Justice Department wants more info on CVS-Aetna deal.

MM&M's Data Week: Demystifying one of pharma's biggest pain points

MM&M's Data Week: Demystifying one of pharma's biggest pain points

By

It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.

Five things for pharma marketers to know: Wednesday, January 31, 2018

Five things for pharma marketers to know: Wednesday, January 31, 2018

By

CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'

CVS/Aetna Combo a Formidable Pharma Rival When it Comes to Access

CVS/Aetna Combo a Formidable Pharma Rival When it Comes to Access

By

The combined company wields greater power to disrupt brand profits.

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

By

Technology like this could expand further to form better collaborations between pharma, payers and organized providers.

More Articles by Marc Iskowitz